CIK 0001130598
- Non-accelerated filer
- Smaller reporting company
Traws Pharma, Inc.
Sign in to watch- Ticker
- TRAW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 267-759-3680
- Business address
- 12 PENNS TRAIL, NEWTOWN, PA, 18940
- Former names
- Onconova Therapeutics, Inc., ONCONOVA THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 26 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-04-26 | Reddy E Premkumar Director | Purchase | +119,048 | $2.10 | $250K | 385,832 |
| 2017-04-26 | Kumar Ramesh President and CEO | Purchase | +23,810 | $2.10 | $50K | 102,227 |
| 2017-04-21 | TYNDALL CAPITAL PARTNERS L P 10% owner | Grant or award | +476,190 | $2.10 | $1000K | 997,022 |
| 2017-01-17 | Maniar Manoj SVP - Product Development | Grant or award · Stock Option (right to purchase) | +19,413 | 19,413 | ||
| 2017-01-17 | Guerin Mark Patrick Chief Financial Officer | Grant or award · Stock Option (right to purchase) | +19,413 | 19,413 | ||
| 2017-01-17 | Kumar Ramesh President and CEO | Grant or award · Stock Option (right to purchase) | +44,027 | 44,027 | ||
| 2017-01-17 | Fruchtman Steven M Chief Medical Officer | Grant or award · Stock Option (right to purchase) | +26,401 | 26,401 | ||
| 2016-12-15 | Fruchtman Steven M Chief Medical Officer | Grant or award · Stock Option (right to purchase) | +7,599 | 7,599 | ||
| 2016-12-15 | Guerin Mark Patrick Chief Financial Officer | Grant or award · Stock Option (right to purchase) | +5,587 | 5,587 | ||
| 2016-12-15 | Kumar Ramesh President and CEO | Grant or award · Stock Option (right to purchase) | +12,673 | 12,673 | ||
| 2016-12-15 | Maniar Manoj SVP - Product Development | Grant or award · Stock Option | +5,587 | 5,587 | ||
| 2016-09-01 | Kumar Ramesh President and CEO | Grant or award · Stock Option (right to purchase) | +44,000 | 44,000 | ||
| 2016-09-01 | Maniar Manoj SVP - Product Development | Grant or award · Stock Option (right to buy) | +17,000 | 17,000 | ||
| 2016-09-01 | Guerin Mark Patrick Chief Financial Officer | Grant or award · Stock Option (right to purchase) | +10,000 | 10,000 | ||
| 2016-09-01 | Guerin Mark Patrick Chief Financial Officer | Grant or award · Stock Option (right to purchase) | +5,000 | 5,000 | ||
| 2016-09-01 | Fruchtman Steven M Chief Medical Officer | Grant or award · Stock Option (right to purchase) | +25,000 | 25,000 | ||
| 2016-08-01 | MARINO JAMES J Director | Option exercise | +24,405 | $4.10 | $100K | 24,415 |
| 2016-08-01 | MARINO JAMES J Director | Option exercise · Warrants (right to buy) | +18,303 | 18,303 | ||
| 2016-07-29 | Bienen Henry S Director | Option exercise | +7,420 | $4.10 | $30K | 8,914 |
| 2016-07-29 | Bienen Henry S Director | Option exercise · Warrants (right to buy) | +5,564 | 5,564 |
Page 17 of 23 · 449 trades